FDA Authorizes First At-Home Sample Collection Test for COVID-19

April 21, 2020 by Dan McCue
FDA Authorizes First At-Home Sample Collection Test for COVID-19
This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. (NIAID-RML via AP)

WASHINGTON – The Food and Drug Administration Tuesday approved the first diagnostic test for the coronavirus that allows people to collect their sample at home — a development that could greatly expand testing options in states fighting to corral the outbreak.

The COVID-19 RT-PCR from LabCorp will initially only be available to health care workers and first responders under a doctor’s orders.

The sample, collected via swab, will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.

Before gaining access to the home test, people are screened using an online questionnaire.

If authorized by a physician, LabCorp will ship a testing kit to their home.

The kit includes cotton swabs, a collection tube, an insulated pouch and box to ship the specimen back to LabCorp. To take a sample, a cotton swab is swirled in each nostril. The test results are posted online to a secure company website.

The company said it will make the test kit available in the coming weeks. Each will cost $119. The kits will not be available in Maryland, New Jersey, New York and Rhode Island. Those states have laws prohibiting testing with at-home kits.

FDA Commissioner Stephan Hawn said in a statement the agency authorized the self-swab test based on data showing it is “as safe and accurate as sample collection at a doctor’s office, hospital or other testing site.”

“Throughout this pandemic we have been facilitating test development to ensure patients access to accurate diagnostics, which includes supporting the development of reliable and accurate at-home sample collection options,” he said.

“The FDA’s around-the-clock work since this outbreak began has resulted in the authorization of more than 50 diagnostic tests and engagement with over 350 test developers,” he continued.

The FDA said it will continue to work with test developers to determine whether or not Q-tip-style cotton swabs can be used safely and effectively with other tests.

A+
a-
  • Coronavirus
  • FDA
  • Food and Drug Administration
  • home testing kit
  • In The News

    Health

    Voting

    Health

    EPA Designates Two Forever Chemicals as Hazardous Substances, Eligible for Superfund Cleanup

    WASHINGTON (AP) — The Environmental Protection Agency on Friday designated two forever chemicals that have been used in cookware, carpets and firefighting... Read More

    WASHINGTON (AP) — The Environmental Protection Agency on Friday designated two forever chemicals that have been used in cookware, carpets and firefighting foams as hazardous substances, an action intended to ensure quicker cleanup of the toxic compounds and require industries and others responsible for contamination to pay for... Read More

    April 18, 2024
    by Beth McCue
    Salmonella Outbreak Linked to Fresh Basil 

    ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic... Read More

    ATLANTA — The Centers for Disease Control and Prevention on Thursday issued a food safety alert regarding Infinite Herbs organic basil. As of the alert, 12 Salmonella cases in seven states have been reported. There are no reported deaths. The basil was sold at Trader Joe’s... Read More

    April 17, 2024
    by Dan McCue
    Eli Lilly Obesity Drug Appears to Ease Sleep Apnea Symptoms in Trials

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its... Read More

    WASHINGTON — A pair of yearlong clinical trials conducted by the drug maker Eli Lilly appear to show that its obesity drug, Zepbound, can provide considerable relief to overweight people who have sleep apnea. Though the findings have yet to be published in a peer-reviewed medical... Read More

    Idaho's Ban on Youth Gender-Affirming Care Has Families Desperately Scrambling for Solutions

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when... Read More

    Forced to hide her true self, Joe Horras’ transgender daughter struggled with depression and anxiety until three years ago, when she began to take medication to block the onset of puberty. The gender-affirming treatment helped the now-16-year-old find happiness again, her father said. A decision by the... Read More

    Weedkiller Manufacturer Seeks Lawmakers' Help to Squelch Claims It Failed to Warn About Cancer

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been... Read More

    DES MOINES, Iowa (AP) — Stung by paying billions of dollars for settlements and trials, chemical giant Bayer has been lobbying lawmakers in three states to pass bills providing it a legal shield from lawsuits that claim its popular weedkiller Roundup causes cancer. Nearly identical bills... Read More

    April 16, 2024
    by Dan McCue
    Agency Sets Rules Limiting Miners’ Exposure to Hazardous Silica Dust

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s... Read More

    WASHINGTON — The Mine Safety and Health Administration issued a new rule on Tuesday aimed at better protecting the nation’s miners from health hazards associated with exposure to respirable crystalline silica, also known as silica dust.  Inhaling crystalline silica, a known carcinogen, can cause serious lung... Read More

    News From The Well
    scroll top